The evidence, curated.
Landmark trials, guideline summaries, and evidence updates — organised so clinicians can find what matters, and patients can see what shapes recommendations.
ASPRE: Aspirin for Prevention of Preterm Preeclampsia
A landmark RCT demonstrating a ~60% reduction in preterm preeclampsia with aspirin 150 mg nightly, started before 16 weeks in screened high-risk women.
- ◆Start before 16 weeks
- ◆150 mg dose
- ◆Screen using combined first-trimester algorithm
ESHRE Guideline on Recurrent Pregnancy Loss — Update
Updated evidence synthesis reshaping investigation thresholds and management pathways for RPL.
- ◆Two-loss threshold
- ◆Selective thrombophilia screen
- ◆APS treatment with aspirin + LMWH
Diagnostic thresholds, management pathways, and criteria for severity in hypertensive disorders of pregnancy.
Structured investigation and management framework for couples with recurrent pregnancy loss.
Global guidance on screening, diagnosis and management of hyperglycaemia in pregnancy.
UK national guidance on diagnosis and management of hypertensive disorders during pregnancy.